Baltruškevičienė, Edita, et al. “Significance of KRAS, NRAS, BRAF and PIK3CA Mutations in Metastatic Colorectal Cancer Patients Receiving Bevacizumab: A single Institution Experience”. Acta Medica Lituanica, vol. 23, no. 1, Apr. 2016, pp. 24-34, https://doi.org/10.6001/actamedica.v23i1.3267.